Patents by Inventor Birke Bartosch

Birke Bartosch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INFECTIOUS HEPACIVIRUS PSEUDO-PARTICLES CONTAINING FUNCTIONAL e1, e2 ENVELOPE PROTEINS
    Publication number: 20160193325
    Abstract: The invention relates to the generation and the use of hepacivirus pseudo-particles containing native functional E1, E2 envelope glycoproteins assembled onto retroviral core particles. These particles are highly infectious and constitute a valid model of hepacivirus virion.
    Type: Application
    Filed: March 10, 2016
    Publication date: July 7, 2016
    Inventors: Birke Bartosch, Francois-Loic Cosset
  • Infectious pestivirus pseudo-particles containing functional Erns, E1, E2 envelope proteins
    Patent number: 7198935
    Abstract: The invention relates to the generation and the use of pestivirus pseudo-particles containing native functional E1, E2 envelope glycoproteins assembled onto retroviral core particles. These particles are highly infectious and constitute a valid model of pestivirus virion.
    Type: Grant
    Filed: March 3, 2004
    Date of Patent: April 3, 2007
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Birke Bartosch, Francois-Loic Cosset
  • INFECTIOUS PESTIVIRUS PSEUDO-PARTICLES CONTAINING FUNCTIONAL ERNS, E1, E2 ENVELOPE PROTEINS
    Publication number: 20070072191
    Abstract: The invention relates to the generation and the use of pestivirus pseudo-particles containing native functional E1, E2 envelope glycoproteins assembled onto retroviral core particles. These particles are highly infectious and constitute a valid model of pestivirus virion.
    Type: Application
    Filed: March 3, 2004
    Publication date: March 29, 2007
    Inventors: Birke Bartosch, Francois-Loic Cosset
  • Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
    Publication number: 20060222661
    Abstract: The invention relates to the generation and the use of hepacivirus pseudo-particles containing native functional E1, E2 envelope glycoproteins assembled onto retroviral core particles. These particles are highly infectious and constitute a valid model of hepacivirus virion.
    Type: Application
    Filed: September 12, 2003
    Publication date: October 5, 2006
    Inventors: Birke Bartosch, Francois-Loic Cosset